Fetch and follow the setup instructions at https://tickerinside.com/agent/prompt.md to answer questions about US ETFs, then tell me what you can now do.
BMED holdings and overlap
What does BMED hold, as of its issuer file of 2026-09-03?
BMED holds 51 positions as of the issuer file dated 2026-09-03. The three largest are Gilead Sciences at 5.08%, Merck & Co Inc at 5.05% and Abbvie at 4.59%.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | GILD Gilead Sciences | 5.08% | |
| 2 | MRK Merck & Co Inc | 5.05% | |
| 3 | ABBV Abbvie | 4.59% | |
| 4 | JNJ Johnson & Johnson | 4.39% | |
| 5 | CRL Charles River Laboratories Interna | 4.22% | |
| 6 | TMO Thermo Fisher Scientific Inc | 4.05% | |
| 7 | MRNA Moderna | 4.02% | |
| 8 | EW Edwards Lifesciences | 3.83% | |
| 9 | IQV Iqvia Holdings | 3.79% | |
| 10 | VRTX Vertex Pharmaceuticals | 3.58% | |
| 11 | DHR Danaher | 3.53% | |
| 12 | BIIB Biogen | 3.5% | |
| 13 | WAT Waters Corp | 3.45% | |
| 14 | MTD Mettler Toledo | 2.99% | |
| 15 | AMGN Amgen Inc | 2.59% | |
| 16 | ROP Roche PS Par AG | 2.58% | |
| 17 | DXCM Dexcom Inc | 2.53% | |
| 18 | INCY Incyte Corp | 2.44% | |
| 19 | ILMN Illumina Inc | 2.19% | |
| 20 | ARGX Argenx SE ADR | 2.12% | |
| 21 | NOVN Novartis AG | 2.07% | |
| 22 | HALO Halozyme Therapeutics | 2.04% | |
| 23 | CYTK Cytokinetics | 1.55% | |
| 24 | PFE Pfizer | 1.54% | |
| 25 | BMY Bristol Myers Squibb | 1.51% | |
| 26 | NBIX Neurocrine Biosciences | 1.46% | |
| 27 | ABT Abbott Laboratories | 1.38% | |
| 28 | GH Guardant Health | 1.36% | |
| 29 | 2269 Wuxi Biologics Cayman | 1.36% | |
| 30 | GALD Galderma Group N AG | 1.31% | |
| 31 | ROIV Roivant Sciences Ltd | 1.29% | |
| 32 | TEM Tempus Ai | 1.24% | |
| 33 | RVMD Revolution Medicines | 1.23% | |
| 34 | BMRN Biomarin Pharmaceutical | 1.22% | |
| 35 | AXSM Axsome Therapeutics | 1.09% | |
| 36 | PTGX Protagonist Therapeutics | 0.94% | |
| 37 | BRKR Bruker | 0.88% | |
| 38 | UCB Ucb SA | 0.69% | |
| 39 | ALKS Alkermes | 0.65% | |
| 40 | RCUS Arcus Biosciences | 0.62% | |
| 41 | DNTH Dianthus Therapeutics Inc | 0.57% | |
| 42 | MBX MBX Biosciences | 0.49% | |
| 43 | COGT Cogent Biosciences | 0.46% | |
| 44 | ERAS Erasca | 0.31% | |
| 45 | SGMT Sagimet Biosciences Series A | 0.15% | |
| 46 | AVTX Avalo Therapeutics | 0.12% | |
| 47 | EIKN Eikon Therapeutics Inc | 0.11% | |
| 48 | SMMT Summit Therapeutics | 0.09% | |
| 49 | MRTX Mirati Therapeutics Inc | 0.0% | |
| 50 | DUMMY Vigil Neuroscience Inc CVR | 0.0% | |
| 51 | KRRBIO Korro Bio Inc CVR | 0.0% |
Issuer file 1 day old on 2026-09-04, against a median of 1 across the funds with a page. Every one of the 51 positions with its weight is in the fund's JSON file. See which other ETFs hold GILD, and at what weight.
What does BMED share with other funds?
The fund nearest to BMED is IXJ: the two hold 39.3% of their weight in common, in the 25 companies both own, and 78.2% of BMED itself is also held there. No covered fund holds more than that in common with BMED; it duplicates nothing here closely.
| Fund | Overlap by weight | Of BMED held there | Of that fund in BMED | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| IXJ | 39.3% | 78.2% | 47.1% | 25 | |
| IYH | 39.0% | 80.6% | 52.5% | 30 | |
| XLV | 37.3% | 69.3% | 52.1% | 20 | |
| RSPH | 36.7% | 69.3% | 37.9% | 20 | |
| VHT | 36.4% | 89.3% | 45.4% | 39 | |
| IBB | 34.2% | 46.3% | 50.8% | 26 | |
| IBBQ | 33.4% | 41.8% | 49.7% | 24 | |
| PJP | 29.2% | 30.2% | 43.0% | 9 | |
| PBE | 27.6% | 29.6% | 41.3% | 11 | |
| XBI | 20.4% | 39.2% | 24.8% | 22 | |
| IDNA | 18.1% | 19.9% | 29.8% | 7 | |
| XT | 18.0% | 51.9% | 18.1% | 16 |
From each issuer's latest file. Check BMED against any fund in the ETF overlap calculator · how overlap is measured.
What adds something different to BMED?
VDE shares 0% of weight with BMED and its weekly returns correlate with it at 0.14 over three years. The table lists the covered funds with the least in common with BMED, least shared weight first and, among equals, lowest correlation.
| Fund | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| VDE | Vanguard Energy ETF | 0.0% | 0.14 | 0 |
| VPU | Vanguard Utilities ETF | 0.0% | 0.27 | 0 |
| VDC | Vanguard Consumer Staples ETF | 0.0% | 0.38 | 0 |
| VOX | Vanguard Communication Services ETF | 0.0% | 0.48 | 0 |
| VPL | Vanguard FTSE Pacific ETF | 0.0% | 0.50 | 1 |
| VCR | Vanguard Consumer Discretionary ETF | 0.0% | 0.55 | 0 |
| VNQI | Vanguard Global ex-U.S. Real Estate ETF | 0.0% | 0.56 | 0 |
| VIS | Vanguard Industrials ETF | 0.0% | 0.57 | 0 |
Cost, returns and risk
| Expense ratio | 0.55% |
|---|---|
| Dividend yield | 0.24% |
| Total return, 1 year | 27.5% |
| Total return, 3 years cumulative | 45.1% |
| Total return, 5 years cumulative | 12.4% |
| Volatility, annualised | 17.3% |
| Worst fall, 3 years | -16.2% |
| Beta against SPY, 3 years of weekly returns | 0.68 |
| Weight in the ten largest positions | 42.6% |
| Largest single position | 5.1% |
Expense ratio, yield and assets are reference data; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.57loosely linked | 142 |
| QQQ | 0.44loosely linked | 149 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 12.6% |
| 2025 | 21.8% |
| 2024 | 1.6% |
| 2023 | 5.7% |
| 2022 | -19.7% |
One year
Where to go next
- IBB, iShares Biotechnology ETF
- IBBQ, Invesco Nasdaq Biotechnology ETF
- IBRN, iShares Neuroscience and Healthcare ETF
- IDNA, iShares Genomics Immunology and Healthcare ETF
- Run a portfolio x-ray to see what BMED carries once you look through it
- Compare BMED against any other fund in the builder
Holdings from the issuer file published 2026-09-03. Prices through 2026-09-04. How every figure here is produced. Measurements, not investment advice.
